title: Experience of tacrolimus-based immunosuppression in living-related liver transplantation complicated with graft tuberculosis: interaction with rifampicin and side effects.
authors.affiliation: Department of Transplantation Immunology, Faculty of Medicine, Kyoto University, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Kiuchi
authors.forename: K
authors.initials: K
authors.lastname: Tanaka
authors.forename: Y
authors.initials: Y
authors.lastname: Inomata
authors.forename: S
authors.initials: S
authors.lastname: Uemoto
authors.forename: K
authors.initials: K
authors.lastname: Satomura
authors.forename: H
authors.initials: H
authors.lastname: Egawa
authors.forename: S
authors.initials: S
authors.lastname: Uyama
authors.forename: K
authors.initials: K
authors.lastname: Sano
authors.forename: H
authors.initials: H
authors.lastname: Okajima
authors.forename: Y
authors.initials: Y
authors.lastname: Yamaoka
mesh_terms: D000328:Adult; D000904:Antibiotics, Antitubercular / Q000627:therapeutic use*; D004347:Drug Interactions; D004977:Ethambutol / Q000627:therapeutic use; D005260:Female; D006650:Histocompatibility Testing; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D007223:Infant; D007538:Isoniazid / Q000627:therapeutic use; D016031:Liver Transplantation / Q000276:immunology*; D019520:Living Donors; D009169:Mycobacterium tuberculosis / Q000302:isolation & purification; D011183:Postoperative Complications; D012293:Rifampin / Q000627:therapeutic use*; D013307:Streptomycin / Q000627:therapeutic use; D016559:Tacrolimus / Q000009:adverse effects / Q000627:therapeutic use*; D014376:Tuberculosis / Q000150:complications / Q000188:drug therapy*
chemical_list: D000904:Antibiotics, Antitubercular; D007166:Immunosuppressive Agents; D004977:Ethambutol; D007538:Isoniazid; D012293:Rifampin; D016559:Tacrolimus; D013307:Streptomycin